Peer Review History

Original SubmissionJune 16, 2021
Decision Letter - Sitara SR Ajjampur, Editor, Pikka Jokelainen, Editor

Dear Dr. Johansen,

Thank you very much for submitting your manuscript "A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: a hierarchical case-case-control study in Ethiopian children" for consideration at PLOS Neglected Tropical Diseases.

As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Sitara SR Ajjampur

Associate Editor

PLOS Neglected Tropical Diseases

Pikka Jokelainen

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: The objectives of study are clearly described. Study design is appropriate to address the objectives

Basic exposures and outcome variables need to define in summary and should include in the manuscript for clear understanding of the readers.

The samples size was not discussed. The samples size is unlikely sufficient to address all the risk factors and multivariate analysis

Statistical analysis was good

The study fulfilled the criteria of ethical or regulatory requirement

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: The analysis was clearly described

The results presented well

Tables and figures are sufficient quality for clarity

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: The conclusion is OK.

There are some limitations which need to address.

The authors addressed the data clearly.

The manuscript has public health importance. The study findings are important for researchers and policy makers.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: The manuscript needs minor revision.

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: The manuscript compares the risk factors of cryptosporidiosis and non- cryptosporidiosis diarrhea cases and cryptosporidiosis vs. control without diarrhea.

The manuscript is well written and addressed case-case-control study design in children < 2 years who suffers most with cryptosporidium diarrhea and infection. This has public health importance to understand risk factors of cryptosporidiosis and to take preventive actions.

However, basic exposures and outcome variables need to define in summary and should include in the manuscript for clear understanding of the readers.

Few following comments are recommend to include in the manuscript preferably or to address.

Define diarrhea case and cryptosporidiosis in the manuscript. Risk factors for diarrhoea cases recruited in community might differ for diarrhoea cases recruited in health care settings. Similarly, diarrhoea severity might have impact on cryptosporidiosis and risk factors. However, this has not been addressed in the manuscript

Moderate acute malnutrition was important predictor for cryptosporidiosis. How SAM/MAM was defined? Diarrhea and dehydration have impact on weight and to assess malnutrition status. This might overestimate MAM/SAM. This should include in discussion.

What was the quantitative cut off value for diagnostic accuracy of cryptosporidiosis? How presence of other pathogens addressed in this quantitative cut off value for diagnosis of cryptosporidiosis?

How sufficient power was maintained to address risk factor analysis?

Minor comments:

Page 2, L-50: The authors recommend following up children with previous illness. The sentence should be more conservative. This might not be feasible in low resources settings. In multivariate analysis, it is indicated as health centre visit due to illness since birth. The diarrhoea was not shown as risk factor in this analysis.

P-22, l-293: The previous illness as mentioned above.

Page 23, L 316-317. Specify age and HIV status to indicate modest effect.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Emily L Deichsel

Reviewer #2: Yes: M. Jahangir Hossain

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Attachments
Attachment
Submitted filename: PNTD 2021_07.docx
Revision 1

Attachments
Attachment
Submitted filename: Letter_response_to_reviewers_PLOS_NTD_REVISION.docx
Decision Letter - Sitara SR Ajjampur, Editor, Pikka Jokelainen, Editor

Dear Dr. Johansen,

Thank you very much for submitting your manuscript "A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: a case-case-control study in Ethiopian children" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Sitara SR Ajjampur

Associate Editor

PLOS Neglected Tropical Diseases

Pikka Jokelainen

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: The methods well written and appropriate. A few suggestions.

Methods state that you applied quantitative cut offs to distinguish asymptomatic and symptomatic crytpo. It’s my understanding that you used quantitative results along with other test results to diagnose crypto infection. Those above the cutoff threshold still had diarrhea (symptoms), just of another cause. These are not asymptomatic crypto infections. That would be the detection of crypto in the controls.

Please also clarify in the main text that no stool testing was done on controls.

How did you handle age for exclusively breastfed for shorter than 6 months. This should be limited to only children who are at least 6 months of age. Based on this discussion it seems those under 6 months were grouped into the not breastfed for 6 months group.

I suggest adding a bit more detail about the PAF mediation analysis completed in the main paper so the reader does not have to see the appendix for this method.

Reviewer #2: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: Results are presented well and presented clearly.

Reviewer #2: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: I think the authors overstate the strong association between crypto diarrhea and malnutrition. To some extent, this association represents the association between any diarrhea and care-seeking and malnutrition (as demonstrated by the NCrD cases). It is established that improving nutrition reduces infectious disease morbidity and the severity of that morbidity. I don’t think you can claim malnutrition and unsafe water as unique characteristics of crypto infection based on this analysis.

Reviewer #2: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: The author’s present a thoughtful, well written, and thorough analysis of risk factors for cryptosporidium and diarrhea in a population of children under two in Ethiopia. The manuscript applies a novel analytic strategy to covers an important and relevant public health topic and is much improved.

Reviewer #2: The Authors have sufficiently addressed earlier comments. The manuscript could be accepted after addressing few following comments.

Abstract, Background, L-34: The authors mentioned in the background that there is a "broad overlap in risk factors between cryptosporidiosis and other diarrhoeal aetiologies". However, this is not very clear how the authors addressed this issue in the manuscript.

Abstract, Methodology/Principal findings: Background, L-40: The authors mentioned that "We applied quantitative cut-offs to distinguish between asymptomatic and symptomatic Cryptosporidium infection". Many of controls were positive to Cryptosporidium infection. However, I don’t see to address this in laboratory analysis section. This sentence is not consistent with the contents of manuscript in method section.

Abstract, Methodology/Principal findings: Background, L: 43-45: The statement “Side-by-side comparisons indicate that socioeconomic factors and public tap water use were more strongly associated with cryptosporidiosis than with non-cryptosporidiosis diarrhoea” is likely not consistent as per table 3 and table 4 especially for socioeconomic factors.

Selection of cases and controls, page 5, L: 122-123: The definition of diarrhea or dysentery needs to be specific. Was the diarrhoea acute or chronic? If diarrhoea is acute, how was it defined to differentiate from chronic diarrhoea?

Fig 1, Level 5: Minor editions: “Previous illness” is termed as “previous healthcare attendance” in revised manuscript. It is recommended to make it consistent throughout the manuscript

Table 1, page 11: The percentages have not corrected/updated for age in months in controls, Cryptosporidiosis and non-cryptosporidiosis.

Table A in S1 Appendix: The number of animal owned (n=1572) in Tab A in S1 Appendix is confusing. The number is more than the denominator (n=725). Are the authors indicating households owned animals or the total number of animals all the household of study participants?

Minor editions:

Introduction, page 4, Line 78: Add “.” at the end of the sentence.

Introduction, page 4, L-96: Delete “-“

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Emily L Deichsel

Reviewer #2: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

Revision 2

Attachments
Attachment
Submitted filename: Letter_response_to_reviewers_PLOS_NTD_2nd_REVISION.docx
Decision Letter - Sitara SR Ajjampur, Editor, Pikka Jokelainen, Editor

Dear Dr. Johansen,

We are pleased to inform you that your manuscript 'A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: a case-case-control study in Ethiopian children' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Sitara SR Ajjampur

Associate Editor

PLOS Neglected Tropical Diseases

Pikka Jokelainen

Deputy Editor

PLOS Neglected Tropical Diseases

***********************************************************

Formally Accepted
Acceptance Letter - Sitara SR Ajjampur, Editor, Pikka Jokelainen, Editor

Dear Dr. Johansen,

We are delighted to inform you that your manuscript, "A comparison of risk factors for cryptosporidiosis and non-cryptosporidiosis diarrhoea: a case-case-control study in Ethiopian children," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .